Search research articles
Contact Us
Filters
Showing results (81-90 of 134) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
October 3, 2023
Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption
Shivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
British Journal of Cancer
|
December 17, 2015
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours
Matthew J Murray, Emma Bell, Katie L Raby, et al.
Andrology
|
October 18, 2022
Small non-coding RNA sequencing reveals global dysregulation of piwi-interacting RNA (piRNA) expression in gonadal malignant germ cell tumours
Sean Laidlaw, Luz Alonso-Crisostomo, Shivani Bailey, et al.
Pediatric Blood & Cancer
|
March 16, 2026
Novel Pediatric Aggressive Adipose Tumor With Pathogenic TERT Promoter Variant and an Initial Durable Response to Vincristine and Dactinomycin
Lucy Hare, Jacqueline Hughes, Michael Morgan, et al.
Eclinicalmedicine
|
March 28, 2024
Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective
Farzana Pashankar, Matthew J Murray, Joanna Gell, et al.
Neuro-Oncology
|
February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials
Adriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.
Frontiers in Oncology
|
July 30, 2024
Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to age
Gilles Palenzuela, Camille Schiffler, Didier Frappaz, et al.
BJU International
|
October 30, 2020
Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours
Aditya Bagrodia, Anna Savelyeva, John T Lafin, et al.
The Journal of Infectious Diseases
|
February 20, 2022
Are the Patterns of Cytomegalovirus Viral Load Seen After Solid Organ Transplantation Affected by Circadian Rhythm?
Hannah Rafferty, Matthew J Murray, Jerry C H Tam, et al.
Molecular Cancer
|
November 10, 2010
The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression
Matthew J Murray, Harpreet K Saini, Stijn van Dongen, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 134) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
October 3, 2023
Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption
Shivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
British Journal of Cancer
|
December 17, 2015
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours
Matthew J Murray, Emma Bell, Katie L Raby, et al.
Andrology
|
October 18, 2022
Small non-coding RNA sequencing reveals global dysregulation of piwi-interacting RNA (piRNA) expression in gonadal malignant germ cell tumours
Sean Laidlaw, Luz Alonso-Crisostomo, Shivani Bailey, et al.
Pediatric Blood & Cancer
|
March 16, 2026
Novel Pediatric Aggressive Adipose Tumor With Pathogenic TERT Promoter Variant and an Initial Durable Response to Vincristine and Dactinomycin
Lucy Hare, Jacqueline Hughes, Michael Morgan, et al.
Eclinicalmedicine
|
March 28, 2024
Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective
Farzana Pashankar, Matthew J Murray, Joanna Gell, et al.
Neuro-Oncology
|
February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials
Adriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.
Frontiers in Oncology
|
July 30, 2024
Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to age
Gilles Palenzuela, Camille Schiffler, Didier Frappaz, et al.
BJU International
|
October 30, 2020
Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours
Aditya Bagrodia, Anna Savelyeva, John T Lafin, et al.
The Journal of Infectious Diseases
|
February 20, 2022
Are the Patterns of Cytomegalovirus Viral Load Seen After Solid Organ Transplantation Affected by Circadian Rhythm?
Hannah Rafferty, Matthew J Murray, Jerry C H Tam, et al.
Molecular Cancer
|
November 10, 2010
The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression
Matthew J Murray, Harpreet K Saini, Stijn van Dongen, et al.
Page
of 14